beta

GNRX

VanEck Vectors Generic Drugs ETF

Gnrx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index. The index includes exchange-listed companies, on a global basis, that derive a significant proportion of their revenues (or that have the potential to derive a significant proportion of their revenues) from the generic drug industry, or that have a primary business focus on the generic drug industry. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. It is non-diversified.

Market Cap: 3.95 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.marketvectorsetfs.com

Shares Outstanding: 150 Thousand

Float: 150 Thousand

Dividend: 0.367 (1.39%)

Beta: 1.270546

Sector:

Industry:

Short Interest (): 0

Ethical Flags

Longest drawdown: 1006 trading days

From: 2018-01-12 To: 2019-04-05

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud